Pharmaceutical

A STAT analysis shows how top drug companies are starting to take action on climate

A STAT analysis shows how top drug companies are starti...

Sep 28, 2023

STAT analyzes pharmaceutical company efforts to reduce greenhouse gas emissions,...

Did the government get a bad deal on the Covid-19 boosters?

Did the government get a bad deal on the Covid-19 boost...

Sep 28, 2023

After Pfizer and Moderna hiked the prices of their Covid vaccines, the governmen...

STAT+: 6 ways the government could help address drug shortages, including in cancer

STAT+: 6 ways the government could help address drug sh...

Sep 28, 2023

Republicans and Democrats alike want to stop drug shortages from happening. The ...

Arcturus Therapeutics extends cystic fibrosis treatment deal

Arcturus Therapeutics extends cystic fibrosis treatment...

Sep 27, 2023

Arcturus Therapeutics has extended an existing agreement in place with the Cysti...

MilliporeSigma opens two new mRNA manufacturing facilities in Germany

MilliporeSigma opens two new mRNA manufacturing facilit...

Sep 27, 2023

MilliporeSigma has opened two new messenger ribonucleic acid (mRNA) drug substan...

Alfasigma to buy Intercept Pharmaceuticals for $794m

Alfasigma to buy Intercept Pharmaceuticals for $794m

Sep 27, 2023

Alfasigma has signed a definitive agreement for the acquisition of Intercept Pha...

Glenmark to market Winlevi in Europe and South Africa after Cosmo deal

Glenmark to market Winlevi in Europe and South Africa a...

Sep 27, 2023

The popular acne treatment will soon be available in 15 EU countries in addition...

Avalyn raises $175m in funding to develop inhaled IPF drugs

Avalyn raises $175m in funding to develop inhaled IPF d...

Sep 27, 2023

The funding was part of an oversubscribed Series C financing that will be used t...

Galecto downsizes by 70% following Phase II trial failure

Galecto downsizes by 70% following Phase II trial failure

Sep 27, 2023

Apart from the workforce cuts, the company is also considering asset divestment ...

Novo Nordisk and Evotec launch translational drug discovery accelerator

Novo Nordisk and Evotec launch translational drug disco...

Sep 27, 2023

The partnership will help advance preclinical concept in the cardiometabolic dis...

Generics expected to improve access for patients with idiopathic pulmonary fibrosis

Generics expected to improve access for patients with i...

Sep 27, 2023

The idiopathic pulmonary fibrosis (IPF) market is underserved with just two lice...

Mobile health strategies: Should you build or partner for success?

Mobile health strategies: Should you build or partner f...

Sep 27, 2023

With GlobalData figures showing the value of pharma’s 2023 digital therapeutics-...

UKHSA signs influenza vaccine deal with CSL Seqirus

UKHSA signs influenza vaccine deal with CSL Seqirus

Sep 27, 2023

UKHSA has signed an advance purchase agreement (APA) with healthcare company CSL...

Women face host of disadvantages in cancer prevention and care, report finds

Women face host of disadvantages in cancer prevention a...

Sep 26, 2023

“The truth is in many ways and many places, women have very little choice to obt...

STAT+: ARPA-H finally settles on its headquarters: hubs in Boston, Texas, and D.C.

STAT+: ARPA-H finally settles on its headquarters: hubs...

Sep 26, 2023

After a drawn out lobbying fight, ARPA-H chose its headquarters: a hub and spoke...

STAT+: Just how much money do drugmakers gain from patent extensions?

STAT+: Just how much money do drugmakers gain from pate...

Sep 26, 2023

Humira made an average $14.6 billion a year after the end of its primary patent,...